FDA Clearance Tracker · K021923
INRATIO SELF-TEST
Last checked: Nov 19, 2026Latest source record: Oct 24, 2002 (this decision)Source: openFDAMethods & limitations
Decided
Oct 24, 2002
Substantially Equivalent
Time to decision
135 days
Received Jun 11, 2002. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K021923
- Device name
- INRATIO SELF-TEST
- Applicant
- Hemosense, Inc.
- Applicant location
- Milpitas, CA
- Received
- Jun 11, 2002
- Decided
- Oct 24, 2002
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Test, Time, Prothrombin (GJS)
- Device class
- Class II
- Regulation
- 21 CFR 864.7750
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code GJS. The earliest in FDA's data is K780203, decided Mar 27, 1978.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K021923
- The applicant filed a summary instead of a public summary, or the summary is not at FDA's usual address. Check the FDA record.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Hemosense, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.